TRCT
NITE

Tower Research Capital (TRC)’s Nightstar Therapeutics plc American Depositary Shares NITE Stock Holding History

Tower Research Capital (TRC)’s Portfolio NITE Stock Details NITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-250
Closed -$6K – 4707
2019
Q1 		$6K Sell
250
-2,661
-91% -$47K ﹤0.01% 3023
2018
Q4 		$34K Buy
+2,911
New +$38.8K ﹤0.01% 1567

Tower Research Capital (TRC)'s NITE Position: Q2 2019 in Review

Tower Research Capital (TRC) sold out of Nightstar Therapeutics plc American Depositary Shares (NITE) in Q2 2019, closing a stake of 250 shares — an estimated $6K sold.

Tower Research Capital (TRC) first reported a position in NITE in Q4 2018 and held it in 2 quarters. The position peaked at $34K in Q4 2018. 0 funds tracked by Wall St. Rank hold NITE as of Q2 2019.

  • Tower Research Capital (TRC) reported no remaining Nightstar Therapeutics plc American Depositary Shares position as of Q2 2019 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 250 Nightstar Therapeutics plc American Depositary Shares shares in Q2 2019, an estimated $6K.
  • Tower Research Capital (TRC) first reported a position in Nightstar Therapeutics plc American Depositary Shares in Q4 2018 and held it in 2 quarters.
  • Tower Research Capital (TRC)'s Nightstar Therapeutics plc American Depositary Shares position peaked at $34K in Q4 2018.
  • 0 funds tracked by Wall St. Rank held Nightstar Therapeutics plc American Depositary Shares as of Q2 2019.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2019, filed 13 Aug 2019.